药物对比
Dapagliflozin vs Vildagliptin
比较 Dapagliflozin 与 Vildagliptin 治疗2型糖尿病：SGLT2与DPP-4抑制剂。疗效、心血管/肾脏获益及副作用方面的主要差异。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes choosing between SGLT2 and DPP-4 inhibitors, especially with cardiovascular or renal comorbidities.
结论
Dapagliflozin may be preferred for added heart and kidney benefits, while Vildagliptin suits those needing straightforward glycemic control.
全部药物对比